Enantioselective organocatalysis has quickly established itself as the third pillar of asymmetric catalysis. It is a powerful technology platform, and it has a tremendous impact in both academic and industrial settings. By focusing on pregabalin, as a case study, this Perspective aims to show how a process amenable to industry of a simple chiral molecule can be tackled in several different ways using organocatalysis.
Asymmetric Organocatalysis—A Powerful Technology Platform for Academia and Industry: Pregabalin as a Case Study / Giorgianni, G.; Bernardi, L.; Fini, F.; Pesciaioli, F.; Secci, F.; Carlone, A.. - In: CATALYSTS. - ISSN 2073-4344. - 12:8(2022), pp. N/A-N/A. [10.3390/catal12080912]
Asymmetric Organocatalysis—A Powerful Technology Platform for Academia and Industry: Pregabalin as a Case Study
Fini F.;
2022
Abstract
Enantioselective organocatalysis has quickly established itself as the third pillar of asymmetric catalysis. It is a powerful technology platform, and it has a tremendous impact in both academic and industrial settings. By focusing on pregabalin, as a case study, this Perspective aims to show how a process amenable to industry of a simple chiral molecule can be tackled in several different ways using organocatalysis.
| File | Dimensione | Formato | |
|---|---|---|---|
|
catalysts-12-00912-v2.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
3.43 MB
Formato
Adobe PDF
|
3.43 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
